INSR and neoplasm: Interestingly, the p53 family of tumor suppressors has been shown to negatively regulate the Insulin-like Growth Factor 1 (IGF-1) Receptor (IGFR-1), an important player of the insulin receptor pathway, through which CR has been proposed to exert its action (Bruchim et al., 2009).